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Abstract: The percentage of patients hospitalized due to hyponatremia is getting higher. 
Hyponatremia is the deficiency of sodium electrolyte in the human serum. This deficiency 
might indulge adverse effects and also associated with longer hospital stay or mortality, if it 
wasn’t actively treated and managed. This work predicts the futuristic sodium levels of patients 
based on their history of health problems using multilayer perceptron (MLP) and multivariate 
linear regression (MLR) algorithm. This work analyses the patient’s age, information about 
other disease such as diabetes, pneumonia, liver-disease, malignancy, pulmonary, sepsis, 
SIADH, and sodium level of the patient during admission to the hospital. The results of the 
proposed MLP algorithm is compared with MLR algorithm based results. The MLP prediction 
results generates 23-72 % of higher prediction results than MLR algorithm. Thus, proposed 
MLR algorithm has produced 57.1 % of reduced mean squared error rate than the MLR results 
on predicting future sodium ranges of patients. Further, proposed MLR algorithm produces 27-
50 % of higher prediction precision rate.  
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1.  Introduction 
Once the human population is suffered by life-threatening diseases such as stroke, 
central nervous diseases, chronic diseases, renal electrolytes imbalance, then the possibility of 
occurrence of the same or indulging side effects is higher. The poor diagnosis, treatments or 
other health problems of the patients might increases the chances of occurrence of the same for 
the second time. These kinds of deadly diseases should be actively overserved and managed 
with intensive care.  
The homeostatic levels of the human body should be maintained within the normal 
range [1]. The healthy adult human body should have the following range; the serum sodium 
(Na+) as 136-145 mmol/L; serum potassium (K+) as 3.3-4.5 mmol/L; serum chloride (Cl-) as 
96-108 mmol/L; urine sodium as 40-220 mmol/day; urine potassium as 25-125 mmol/day; 
urine serum chloride as 110-250 mmol/day [2, 3]. Any abnormalities in these recommended 
range might indulge adverse effects in the human body and its severity is based on the level of 
homeostatic concentration or dilution.  
The inappropriate antidiuretic hormone secretion might leads to cause the rapid loss of 
sodium in the serum of human. The loss of serum sodium concentration in human blood is 
called as hyponatremia. The sodium level in the blood is diluted by the excess water intake and 
frequent urination. Typically, the hyponatremia is a common disorder and is being observed in 
many hospitalized patients [4]. It can lead to mortality of the patient, if the required essential 
treatments is not given. Even with the adequate intensive treatments the percentage of mortality 
is high for the patients with hyponatremia [5]. The hyponatremia also found in patients with 
the excessive Arginine Vasopressin (AVP) hormone in the plasma of the blood. 
The hyponatremia can be categorized into acute and chronic based on the concentration 
rate of the serum sodium. The too lower serum sodium concentration is very deleterious and it 
can affect the normal functions of other organs of the human body [6]. Typically, the most 
frequent hyponatremia might leads to serious complications in the central nervous system. The 
patients with acute hyponatremia should be given with intensive and prompt treatments; 
otherwise, it might lead to life-threatening. The chronic hyponatremia develops the non-renal 
diseases in other organs of the human body, which often increases the morbidity and mortality.  
The poor prognosis and treatments given to the patients with hyponatremia leads to 
increase the length of hospital stay, especially for the heart patients [7]. The hyponatremia 
might be managed optimally with prompt treatments to the patients, which may increase the 
serum sodium concentration and reduces the severity and in-hospital mortality. The prompt 
diagnosis and optimal recognized treatments of hyponatremia to the patients might be helpful 
for improving their body conditions to normal and also allows them to the normal 
hospitalization, reduces the duration of hospitalization and hospitalization costs as well [8].  
Increasing the serum sodium concentration too rapidly might leads to life-threatening 
diseases and sequel side effects. The serum sodium must be increased by recommended level 
only; otherwise it increases the possibility of fatal heart or neurologic disorders [9]. One of the 
major therapies provided to the hyponatremia is associated with the blocking the actions of the 
arginine vasopressin receptors to resist from elimination of electrolytes during the urination; it 
might raise up the serum sodium concentration [10].  
The serum sodium concentration should be managed within the recommended range; 
also based on the homeostatic mechanisms, AVP, renal water excretion, and thirst. Any 
abnormal changes with the electrolytes of blood, renal chemical levels, and water level could 
lead to hyponatremia. Even, a small unbalance in the renal functions, which was not treated 
carefully could increase the possibility of consistent morbidity or on severe condition may be 
death as well [11, 12]. The adverse effects of the hyponatremia on the human population 
motivates the research work on prediction of future sodium ranges and possibility of 
readmission due to hyponatremia on patients. This research work uses the regression and neural 
networks for the analysis of sodium ranges. 
The remainder of the section is organized as follows. The section 2 reports the existing 
literature works about hyponatremia. The symptoms, causes, existing diagnosis, treatments, 
effects of hyponatremia. The section 3 explains the proposed methodology and its stepwise 
details to predict the future sodium ranges for the patients under the hyponatremia treatment. 
The prediction results analysis and evaluation of the proposed methodology is presented in the 
section 4. Finally, section 5 concludes with future enhancements.  
2.  Literature survey 
This section summarizes the brief review of existing literacy works that addresses the 
importance of hyponatremia and appropriate treatments. Numerically the hyponatremia is 
defined as the incident that the serum sodium concentration (Na +) reduces below to 136 
(normal range 136–145) mEq/l. This type of disorder is common in many hospitalized patients. 
As mentioned earlier, the excessive water retention in the body or very frequent urination 
causes the disorder of dilutional hyponatremia [13]. The water intake should not exceed the 
kidneys’ excretory capacity. If exceeds, it causes the sodium dilution in the serum, which may 
lead to hyponatremia, hypo-tonicity, and hypo-osmolality [14].  
Typically, the patients will drink more water, if they are affected by syndrome of 
inappropriate antidiuretic hormone secretion (SIADH); since the SIADH patients always feels 
thirst. The treatments and medications are provided to the patients with hyponatremia based on 
their age, severity, hormone conditions, renal dysfunction, chronic disease, adrenal level, and 
nervous system [15, 16]. A variety of drugs associated with the treatment of hyponatremia are 
sulfur-containing diuretics drugs, vasopressin receptor antagonist drugs, tolvaptan, 
desmopressin, etc.; these drugs might reduce the risks related to the hyponatremia. The falsely 
prognosis of low serum sodium concentration is termed as pseudohyponatremia. It can 
happens, when the patients having extreme hyperlipidemia or hyperproteinemia and it is 
identified by flame photometry or indirect potentiometry [17]. 
In most of the cases, the excessive AVP secretion with the absence of elevated plasma 
osmolality is the major issue that causes the hyponatremia. The kidney may retain the water 
because of the elevated AVP secretion. Thus, the reduced water excretion and increased AVP 
concentration have direct association with them [18]. The patients having too-much AVP 
secretion and exceeding their water intake by 800 ml/day might cause the water retention; and 
also it dilutes the fluid compartments, which leads to cause hyponatremia. 
Based on the age, the occurrence of hyponatremia increases and also the documented 
studies suggests that the old aged people have higher percentage; such that 60-aged population 
have 53% of this disorder in a year. Further, SIADH disorder is most common in majority of 
hospitalized patients with hyponatremia [19]. The valproic acid plays a major role on 
controlling the Na+ channels. It is an 8-carbon 2-chain fatty acid and human’s liver metabolizes 
it [20]. The valproic acid mediates for the management and recovery of serum sodium 
concentration through the depolarization of spinal cord and cortical neurons for the patients.  
Typically, its therapeutic range should not exceed 50-100 mcg/mL per dosage [21]. 
While its range produce positive responses with minimal side effects experienced by the 
patients. Also, the level of valproic acid in the blood level should be monitored and altered 
within the recommended range based on the patients’ responses in a less frequent but regular 
interval. The time taken to make effects by the valproic acid on the human body varies between 
the patients [22].  
The subtherapeutic/supratherapeutic levels of valproic acid to patients, might make 
them to the risk conditions or indulges toxic side effects. If required, the additional 
testing/treatments should be given to the patients based on medication’s 
effectiveness/ineffectiveness, patient’s side effects, effects on the central nervous system, and 
other complications faced by the patients [23]. Further, the patients with multiple medications 
should be taken additional care with continuous evaluation of valproic acid level because of 
the interaction of other medications. Also, protein level in the blood also essentially be 
monitored because supratherapeutic valproic acid level has more influence on it [24].  
The research gap in predicting future sodium range of the patients motivates this 
research work and analysis of possibility of readmission due to hyponatremia. Table.1 
summarizes the top direct evident chemicals and genes which are associated with 
hyponatremia. The Interferon-gamma (IFNG), Arginine Vasopressin (AVP), Oxytocin (OXT), 
TRPV4 (Transient Receptor Potential Cation Channel Subfamily V Member 4) are most 
evident genes and hormones with the hyponatremia. 
3.  Methodology  
This section describes the methodologies for the prediction of the future sodium ranges 
of the patients affected by the hyponatremia. The multilayer perceptron and multivariate linear 
regression techniques are adopted in this work for the prediction of future values of the sodium.  
The proposed methodology makes the analyses and predicts the futuristic sodium levels 
of patients based on their history of health conditions. This research work also facilitates the 
way to forecast the possibility of the occurrence of hyponatremia once again using artificial 
intelligence-based algorithms. Further, to emulate the futuristic healthcare of the patients based 
Table.1 Chemicals and genes associated with hyponatremia based on direct evidence 
S. No. Chemical Inferring Genes/Hormones 
1. Valproic Acid AVP, IFNG, OXT 
2. Cisplatin IFNG 
3. Dinoprost IFNG, OXT 
4. Clonidine AVP, IFNG 
5. N-Methyl-3,4-
methylenedioxyamphetamine 
TRPV4 
6. Chlorpropamide AVP 
7. Fluoxetine AVP, IFNG, OXT 
8. Colchicine AVP, IFNG 
9. Mesna AVP 
10. Fluvoxamine AVP 
11. Indomethacin AVP, IFNG, TRPV4 
12. Hydrochlorothiazide AVP 
13. Enalapril AVP 
14. Haloperidol AVP 
15. Ifosfamide AVP 
16. Carbamazepine IFNG 
17. Amiloride IFNG 
18. Isoproterenol AVP, IFNG 
19. Spironolactone IFNG 
20. Fluorouracil IFNG 
21. Vincristine AVP, IFNG, TRPV4 
22. gemcitabine IFNG 
23. Cyclophosphamide IFNG 
24. Omeprazole IFNG 
25. Ibuprofen IFNG 
26. Tacrolimus IFNG 
27. Theophylline IFNG 
 
on their previous history of illness/diseases, the proposed research work had developed a MLR 
and MLP based future health prediction algorithm.  
3.1 Dataset 
The dataset this research is obtained from Cerner Health Facts database. This is a 
dataset of hospitalized patients during January 2000 and November 2014 collected from 
various clinics and hospitals in the United States [9]. The dataset contains one million patients’ 
information. The details of the patients such as age (A), gender (G), information about diabetes 
(D), pneumonia (P), liver-disease (L), malignancy (M), pulmonary (Pu), sepsis (Se), SIADH 
(S), and sodium level (Na) during admission are taken for this research analysis.  
The patients are grouped into four categories based on their ages. The age groups are 
(i) 18 to <45, (ii) 45 to <65, (iii) 65 to <75, (iv) ≥75 years old [9]; similarly, based on gender 
the patients are grouped namely male and female for the training and learning by the MLR and 
MLP algorithms.  
3.2 Multivariate Linear Regression (MLR) Algorithm 
The multivariate linear regression is the knowledge based learning algorithm, works 
based on training of the dataset. The MLR can be defined as improved knowledge driven expert 
system [25]; it generates linear hypothesis and determines the weights for the given variable 
based on the learning process and parameters [26]. The multivariate linear regression algorithm 
is a statistics based model.  The MLR algorithm describes the relationship between two or more 
dependent and independent variables based on the given dataset [27].  
The MLR algorithm computes and analyses the regression for producing the optimized 
or appropriate results [28]. It also determines the correlation and assesses the testing/validation 
and usefulness of the model using various stages of multivariate linear regression model [28, 
29]. The MLR can be defined as denoted in the equation (1). 
𝑀𝐿𝑅𝑖(𝑎, 𝑏, 𝑘) =  𝜑 +  𝛼1𝐴 +  𝛼2𝐺 + 𝛼3𝐷 +  𝛼4𝑃 +  𝛼5𝐿 +  𝛼6𝑀 +  𝛼7𝑃𝑢 +  𝛼8𝑆𝑒 +  𝛼9𝑆 
+ 𝛼10𝑁𝑎             (1)  
In the equation 1,  𝛼1, … … … , + 𝛼10 are the set of additive predictor functions, 𝜑 is the 
intercept associated with each functions [30], the variable ‘A’ represents the patient’s age, The 
gender of the patient is denoted as ‘G’, the variable ‘D’ is denotes the patients with diabetes, 
patients with pneumonia is given as ‘P’, ‘L’ gives the patients with liver-disease, ‘M’ is 
malignancy, ‘Pu’ is pulmonary, ‘Se’ is sepsis, ‘S’ is SIADH, ‘Na’ is the sodium level of the 
patients during admission to the hospital.  
3.3 Multilayer Perceptron (MLP) 
Typically, in a simple three-layer network, there will be input layer in the first, hidden 
layer in the middle, and output layer in the last. In the input layers, the input dataset will be 
feed, while the output layer contains the output, which is generated based on the dataset given 
to the input layer and computations from the hidden layer. The number of hidden layer can be 
varied (increased/decreased) based on the complexity of the given problem [37]. In general the 
main objective of any neural network model is to optimize or approximate the given function 
f(x). Similarly, the multilayer perceptron neural network model will find the best optimized or 
approximate solution to the given complex problem by using techniques such as classification, 
regression, or mapping functions [31].  
The MLP is a supervised learning technique and each neuron uses a nonlinear activation 
function and backpropagation for training. The MLP networks consists of several chained 
functions. Let consider, a classifier problem y= f(x); here the output y is driven by the input x 
and its corresponding mapping solution given by MLP based on the best approximation of the 
given classifier function. Such that the MLP computes the best optimized solution as y = f(x; 
θ); where θ is the learning parameter of given problem. For example, the three layer MLP 
network can be formulated as f(x) = f (x3) (f (x2) (f (x1) (x))). In each layer, the MLP performs 
several defined transformation and/or linear summation functions with the inputs. In MLP, 
each of these layers are symbolized as y = f (W.x.T + b); where the activation functions is 
denoted as f, the weights or set of parameter of the problem are indicated as w, the variable x 
is the input, and b represents the bias vector [32].  
In MLP, the output of previous layer is the input to the next layer. Such that the layers 
of the MLP of fully connected with each other layers in the network. Thus, each unit functions 
of the layer are always connected to the all other layers’ unit function in the neural network. 
Although, each layer’s unit functions (i.e. weights and other set of parameters) are independent 
to other layer’s unit functions. It means the weights of the each layer’s unit functions are 
unique. Further, the MLP network defines the loss function, which can measure the 
performance of the MLP’s classification or regression technique. When the loss function has 
high value, the MLP doesn’t made accurate classification or prediction solution to the given 
problem and otherwise it is vice versa [31, 32].  
Fig.1 depicts the flow of the proposed MLP based Future sodium prediction algorithm. 
Firstly, one million patients hyponatremia dataset collected from the hospitals. The outlier and 
missing data are removed from the hyponatremia dataset using imputation process. Then the 
0.5 million of hyponatremia dataset is given to the input layer as the input and it is trained by 
using the multilayer perceptron algorithm. To obtain the better optimal prediction model, the 
number hidden layers are varied from two to twenty by the unit of two. This MLP learning and 
training process gives the prediction results in the output layer.  
The prediction results are evaluated for the quality check of the prediction by using the 
Akaike Information criterion (AIC) and Bayesian Information criterion (BIC). Again, the error 
performance metrics such as Mean Squared Error (MSE), Root Mean Squared Error (RMSE), 
Mean Absolute Error (MAE), Mean Absolute Relative Error (MARE), and Root Mean Squared 
Relative Error RMSRE (RMSRE) are computed for the prediction results. The AIC, BIC 
analysis and error performance metrics computation results us the best quality future sodium 
prediction dataset [33, 38]. The performance results of the future sodium prediction dataset are 
analyzed with the precision rate and compared with other existing results. 
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4.  Results Evaluation and Discussion 
This section gives the detailed results analysis, evaluation of performance metrics, and 
comparative result analysis.  
4.1  Results of MLR Algorithm 
In order to predict the future sodium range, the multivariate linear regression algorithm 
trains the 0.5 million dataset containing the patients’ information such as age (A), gender (G), 
information about diabetes (D), pneumonia (P), liver-disease (L), malignancy (M), pulmonary 
(Pu), sepsis (Se), SIADH (S), and sodium level of the patients during admission to the hospital 
(Na). The MLR algorithm trains the 0.5 million patients dataset and performs the testing and 
validation operations on the given dataset and finally produces the dataset for the future sodium 
range values. 
In order to determine the quality dataset for the prediction of the future sodium values, 
generalized regression parameters such as (a, b, k) are varied; where the parameter a is the 
number of input channels, b is the number of output channels and k represents the delay value. 
The (a, b, k) parameters are varied as  (1,2,1), (1,2,2), (2,2,1), (2,2,2), (2,2,3), (2,3,2), (2,3,3), 
(3,2,1), (3,2,2), and (3,3,2). Table 2, summarizes the results of error performance metrics such 
as MSE, RMSE, MAE, MARE, and MSRE for the MLR parameters (a, b, k) using the MLR 
algorithm [33].  
As per definition of MSE, the resultant lowest MSE value among the different (a, b, k) 
parameter gives the feasible realistic solution. Therefore in Table 2, the lowest MSE value that 
is (a, b, k) parameter (2,2,1) are highlighted with boldface. The error performance metric values 
Table.2 Performance Error Metrics resulted by MLR 
Error Metrics/ 
(a, b, k) 
MSE RMSE MAE MARE RMSRE 
(1,2,1) 0.215 0.4637 0.4386 0.107 0.1148 
(1,2,2) 0.2643 0.5141 0.4849 0.1173 0.1247 
(2,2,1) 0.1894 0.4352 0.4162 0.1036 0.1121 
(2,2,2) 0.2668 0.5165 0.4908 0.1192 0.1263 
(2,2,3) 0.2923 0.5406 0.5097 0.123 0.1303 
(2,3,2) 0.2585 0.5084 0.4794 0.1161 0.1236 
(2,3,3) 0.5028 0.7091 0.6688 0.1611 0.1699 
(3,2,1) 0.2152 0.4639 0.439 0.1071 0.1149 
(3,2,2) 0.2671 0.5168 0.491 0.1193 0.1264 
(3,3,2) 0.2585 0.5084 0.4795 0.1161 0.1236 
 
for the MSE, RMSE, MAE, MARE, and MSRE for the MLR parameters (2,2,1) are 0.1894, 
0.4352, 0.4162, 0.1036, and 0.1121 respectively; it is the lowest among other (a, b, k) 
parameters. Therefore, the corresponding dataset of the (2,2,1) parameter is considered as the 
appropriate and optimistic solution for the given hyponatremia patient dataset.  
In addition, the results of AIC and BIC metrics for the MLR algorithm given in Table 
3 confirms that the (2,2,1) parameter produces the lowest metric results. As per the AIC and 
BIC definition, the better quality and stable can be given by the lowest AIC or BIC valued 
corresponding dataset. In Table 3, the boldfaced (2,2,1) parameter gives the lowest AIC and 
BIC metrics such as 2211.489 and 2214.856 respectively. The resultant values of AIC, BIC, 
and error metrics confirms that the dataset of (2,2,1) parameter produces better prediction 
results. Therefore, the parameter (2,2,1)’s corresponding dataset is taken as the result of the 
future sodium prediction values.  
4.2  Results of MLP Algorithm 
The multilayer perceptron algorithm trains the dataset containing the 0.5 million 
patients’ information such as age (A), gender (G), information about diabetes (D), pneumonia 
(P), liver-disease (L), malignancy (M), pulmonary (Pu), sepsis (Se), SIADH (S), and sodium 
level (Na) of the patients during admission to the hospital. In order to determine the quality 
dataset for the prediction of the future sodium values, the number of hidden neurons are varied 
from two to twenty [34, 36]. Table. 4 summarizes the resultant performance error metrics 
values such as MSE, RMSE, MAE, MARE, and MSRE for the MLR algorithm with several 
different neurons.  
Table.3 Results of AIC and BIC Metrics for MLR 
Criterion/ 
(a, b, k) 
AIC BIC 
(1,2,1) 731809.6 731776.2 
(1,2,2) 811329.74 813626.37 
(2,2,1) 591230.55 593907.18 
(2,2,2) 611590.781 662324.148 
(2,2,3) 672218 672351.3 
(2,3,2) 600211 600215 
(2,3,3) 768794.9 768828.3 
(3,2,1) 733165.4 733132.1 
(3,2,2) 720541.85 780735.22 
(3,3,2) 822211.59 901378.22 
 
In Table. 4, the lowest MSE value is highlighted as neuron 6. The error performance 
metric values for the MSE, RMSE, MAE, MARE, and MSRE for the neuron 6 by MLP 
algorithm are 0.0227, 0.1505, 0.0691, 0.0196, and 0.0441 respectively; it is the lowest among 
other neurons. Therefore, the corresponding dataset of the neuron 6 is considered as the 
appropriate and optimistic solution for the given hyponatremia patient dataset. 
Moreover, the results of AIC and BIC metrics for the MLP algorithm is summarized in 
Table 5. It confirms that the neuron 6 generates the lowest metric results. In Table 3, the 
boldfaced (2,2,1) parameter gives the lowest AIC and BIC metrics such as 525639.24 and 
525605.88 respectively. The resultant values of AIC, BIC, and error metrics confirms that the 
dataset of neuron 6 produces better prediction results. Therefore, the neuron 6’s corresponding 
dataset is considered as the result of the future sodium prediction values in this scenario. 
 
Table.5 Results of AIC and BIC Metrics for MLP 
Criterion/Neurons AIC BIC 
2 950044.093 950021.848 
4 759348.725 759326.48 
6 525639.24 525605.88 
8 780974.062 780951.818 
10 950819.348 950797.103 
12 708582.641 708560.397 
14 777258.361 777236.116 
16 764183.817 764161.572 
18 832843.723 832821.478 
20 757474.068 757451.823 
 
Table.4 Performance Error Metrics resulted by MLP 
Metrics/Neurons MSE RMSE MAE MARE RMSRE 
2 0.052 0.2281 0.1521 0.0418 0.073 
4 0.1012 0.3181 0.2791 0.071 0.0919 
6 0.0227 0.1505 0.0691 0.0196 0.0441 
8 0.0942 0.3069 0.273 0.07 0.0898 
10 0.0563 0.2372 0.1693 0.0492 0.1017 
12 0.1092 0.3304 0.2975 0.0752 0.0956 
14 0.1014 0.3184 0.2832 0.0728 0.0967 
16 0.1018 0.3191 0.2862 0.0727 0.0914 
18 0.0806 0.2839 0.248 0.0636 0.0773 
20 0.1005 0.317 0.2848 0.0722 0.0894 
 
4.3 Result analysis for MLR and MLP algorithm 
The future sodium prediction results obtained by the techniques MLR and MLP are 
compared for the analysis of accurate prediction of results. Fig. 2 gives the comparative future 
sodium prediction results by using the techniques MLP and MLR for the critical hyponatremia 
patients. The observed and predicted results of patient’s serum sodium range such as less than 
120, 120 to 125, and 126 to 130 are depicted in the Fig.2. For the sodium range less than 120 
category, the total number of observed patients are 2568; the proposed MLP algorithm had 
predicted the total number of patients under less than 120 category as 2537; whereas, the MLR 
had predicted it as 5399 patients for the less than 120 category.  
The proposed MLP algorithm had produced higher accuracy of prediction, in which the 
prediction difference with the observed results is 1.21 % only; whereas the MLR algorithm has 
prediction difference with the observed results as 71 %. The total number of observed patients 
for the sodium range 120 to 125 category is 9639; the proposed MLP algorithm had predicted 
the total number of patients for the 120 to 125 category as 10554; whereas, the MLR had 
predicted it as 15370 patients for the same category. In this case, the prediction difference with 
the observed results MLP and MLR algorithms are 9 and 45 % respectively. 
Similarly, For the sodium range 126 to 130 category, the total number of observed 
patients are 45024; the proposed MLP algorithm had predicted the total number of patients for 
the 126 to 130 category as 42797; whereas, the MLR had predicted it as 25711 patients for the 
same category. Correspondingly, the MLP algorithm has lower prediction difference with the 
 
Fig. 2. Comparison of Na+ prediction results by MLP and MLR (Critical) 
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observed results as 5 %; whereas, the MLR algorithm has higher prediction difference with the 
observed results as 54.6 %. 
For the stable hyponatremia patients, the comparative future sodium prediction results 
by using the techniques MLP and MLR are depicted in Fig. 3. The total number of observed 
patients for the sodium range 131 to 135 category is 300187; the proposed MLP algorithm had 
predicted the total number of patients for the same category as 305875; whereas, the MLR had 
predicted it as 385388 patients for this category. In this case, the prediction difference with the 
observed results MLP and MLR algorithms are 1.8 and 24.8 % respectively. 
Similarly, For the sodium range 136 to 138 category, the total number of observed 
patients are 142582; the proposed MLP algorithm had predicted the total number of patients 
for the same sodium category as 13827; whereas, the MLR had predicted it as 68117 patients 
for the same category. In the same way, the MLP algorithm has lower prediction difference 
with the observed results as 3.1 %; whereas, the MLR algorithm has higher prediction 
difference with the observed results as 70.6 %. 
Table.6 gives the best results of performance error metric for the proposed MLP and 
MLR algorithms. The appropriate stable dataset (2,2,1) discovered by the MLR algorithm has 
the performance error metrics such as MSE, RMSE, MAE, MARE, and MSRE as 0.1894, 
0.4352, 0.4162, 0.1036, and 0.1121 respectively. Similarly, quality dataset (neuron 6) 
Table.6 Error Metrics result analysis for MLR and MLP 
Metrics/Algorithm MSE RMSE MAE MARE RMSRE 
MLR 0.1894 0.4352 0.4162 0.1036 0.1121 
MLP 0.0227 0.1505 0.0691 0.0196 0.0441 
 
 
Fig. 3. Comparison of Na+ prediction results by MLP and MLR (Stable) 
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determined by the proposed MLP algorithm has the performance error metrics such as MSE, 
RMSE, MAE, MARE, and MSRE as 0.0227, 0.1505, 0.0691, 0.0196, and 0.0441 respectively. 
Henceforth, these confirms that the proposed MLP algorithm had generated the lower error 
rates than the MLR error rates.  
Fig.4. gives the patients’ age wise hyponatremia prediction results based on the MLP 
algorithm. From this pie chart, it can be seen that the patients with below the age of 45 are 
getting affected by the hyponatremia is very less (i.e.) 17 %. When the patients’ age is above 
75 or the patients’ age is 46 to 65 then the number of patients getting affected by the 
hyponatremia is very high (i.e.) 32 %. In between the age of 66 to 75 there are 19 % of patients 
had treatment for hyponatremia. Fig.5 illustrates the pie chart analysis on MLP based 
hyponatremia prediction results based on gender. From the Fig. 5, it is clear that female patients 
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Fig. 5. Gender wise hyponatremia prediction by MLP 
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are highly suffered by hyponatremia than the male patients. Such that 54 % of female patients 
had treatments for the hyponatremia, whereas 46 % of male patients only had treatments for 
hyponatremia from the dataset of 0.5 million patients. 
4.4 Computation and analysis of Precision rate  
In order to analyse the accuracy of prediction results of the MLR and MLP algorithms, 
the precision rate is calculated. The prediction precision rate is the percentage of root of squared 
difference rate between the predicted and observed results calculated using the Euclidean 
distance [35]. It is given in the equation (2) as,  
𝑃𝑅 = {1 − (
𝐸𝑈𝐶𝐷𝑖𝑠
𝐸𝑈𝐶𝑚𝑎𝑥
)} ∗ 100                                                    (2) 
𝐸𝑈𝐶𝐷𝑖𝑠 = √(𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 − 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑)2 
Where, 𝐸𝑈𝐶𝐷𝑖𝑠 denotes the Euclidean distance and 𝐸𝑈𝐶𝑚𝑎𝑥 represents the maximum 
Euclidean distance among predicted and observed serum sodium results [35]. Table.7 gives the 
accuracy of the prediction results using precision rate analysis. In Table.7, for the different 
serum sodium range such as less than 120, 120 to 125, 126 to 130, 131 to 135, and 136 to 138, 
the proposed MLP algorithms has the prediction precision rates as 98.7928, 90.5073, 95.0537, 
98.1052, and 96.9456, whereas the MLP algorithms has the prediction precision rates as 
51.2414, 40.5436, 57.1051, 71.6174, and 47.7739. The proposed MLP algorithm has the 
prediction accuracy of 90.5 to 98.7 %, whereas the MLR algorithm has the prediction accuracy 
of 40.5 to 71.6 %. Such that the proposed MLP algorithm has 27-50 % of higher precision rate 
on predicting the future sodium range of the patients.  
Table. 8 gives the summary of percentage of difference (PD) among the observed 
results, MLR algorithm based prediction results, and MLP algorithm based prediction results. 
Table.7 Precision rate for MLR and MLP 
Precision Rate (%) 
Algorithm/ 
Na+ Range 
MLR MLP 
<120 51.2414 98.7928 
120 to 125 40.5436 90.5073 
126 to 130 57.1051 95.0537 
131 to 135 71.6174 98.1052 
136 to 138 47.7739 96.9456 
 
In this analysis the proposed MLP algorithm were produced only 1.2 to 9 % of difference with 
the observed results; whereas the MLR algorithm based prediction results has 24.8 to 71 % of 
difference with the observed results. Since, the proposed MLP algorithm were produced 23.6 
to 62 % of reduced percentage of difference with the observed results. As well as the improved 
results by the MLP prediction results as compared with MLR prediction results is 23-72 %. 
5. Conclusion 
 This work were concentrated on prediction of future sodium range for the patients 
based on various health history factors such as age, gender, health problems, etc. in order to 
predict the hypo/hyper-natremia. The proposed MLP algorithm has produced the accurate 
future serum sodium prediction range than the MLR algorithm. The MLR algorithm has the 
prediction accurate rate of 41-72 %, whereas the MLP neural network algorithm has the 
accurate prediction of 91-99 %. The MLP algorithm based prediction results has 27-50 % of 
improved prediction accuracy than the MLR algorithm based prediction results. Moreover the 
proposed MLR algorithm based prediction results 57.1 % of reduced MSE error rate than the 
MLR results on predicting future sodium ranges of patients. The outcome of the proposed MLP 
algorithm based future health prediction algorithm could be more helpful for physicians and 
patients to make further decisions based on their health conditions. Based on these results the 
future work will concentrate on forecasting the possibility of the occurrence of hyponatremia 
once again using machine learning prediction algorithms. 
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Table.8 Percentage of Difference for Observed, MLR, and MLP results 
 PD (%) 
Results/ 
Na+ Range 
MLP with 
observed results 
MLR with 
observed results 
MLP with  
MLR results 
<120 1.2145 71.0682 72.127 
120 to 125 9.0625 45.8315 37.1548 
126 to 130 5.0717 54.6066 49.8803 
131 to 135 1.877 24.8553 23.0051 
136 to 138 3.1018 70.6838 67.9545 
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